From Financialisation to Innovation in UK Big Pharma

This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Tulum, Öner, Andreoni, Antonio, Lazonick, William
Formaat:	Online
Taal:	Engels
Gepubliceerd in:	Cambridge University Press 2024
Onderwerpen:	corporate governance taxation thema EDItEUR::K Economics, Finance, Business and Management::KC Economics thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJM Management and management techniques thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJC Business strategy thema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJD Business innovation thema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
Online toegang:	ONIX_20240819_9781009278140_103
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Wees de eerste die reageert!

From Financialisation to Innovation in UK Big Pharma

Gelijkaardige items